Skip to Content

Watson 369 5 mg (Loxapine Succinate 5 mg)

Pill with imprint Watson 369 5 mg is White, Capsule-shape and has been identified as Loxapine Succinate 5 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 369 5 mg

Loxapine succinate 5 mg Watson 369 5 mg
Loxapine succinate 5 mg Watson 369 5 mg
Loxapine succinate 5 mg Watson 369 5 mg

Loxapine Succinate

Imprint:
Watson 369 5 mg
Strength:
5 mg
Color:
White
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
lactose anhydrous
benzyl alcohol
butylparaben
edetate calcium disodium
gelatin
magnesium stearate
methylparaben
polacrilin potassium
propylparaben
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide